© 2004 by Oxford University Press
© 2004 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Vincent T. DeVita Jr., M.D., has been named the Amy and Joseph Perella Professor of Medicine at Yale University in recognition of his contributions to cancer research and treatment. Director of Yale Cancer Center from 1993 to 2003, DeVita currently serves as chairman of the Yale Cancer Center Advisory Board and is a Yale University School of Medicine Professor of Internal Medicine and Epidemiology and Public Health. He was the director of the National Cancer Institute from 1980 to 1988.
Joseph R. Perella is chairman of Institutional Securities and Investment Group Banking at Morgan Stanley. His wife, Amy Perella, is a survivor of Hodgkin’s disease. Mr. and Mrs. Perella gave $2.5 million for the endowed position. Following DeVita’s tenure, the chair will be renamed the Vincent T. DeVita Professor of Medicine.
Stephen A. Feig, M.D., was awarded the 2003 Gold Medal by the Society of Breast Imaging in recognition of his contributions to breast imaging research. Feig is a professor of radiology at Mount Sinai School of Medicine and Director of Breast Imaging at Mount Sinai Hospital, New York, NY.
The American Association for Cancer Research announced the winners of its annual awards.
The recipient of the 2004 Pezcoller Foundation-AACR International Award for Cancer Research was Stanley J. Korsmeyer, M.D., Sidney Farber Professor of Pathology and professor of medicine at the Dana-Farber Cancer Institute at Harvard Medical School. Korsmeyer was honored for defining the role of the genetic mechanisms that govern apoptosis and survival, leading to the development of individualized treatments of lymphomas and other cancers.
Frederick W. Alt, Ph.D., a Howard Hughes Medical Institute investigator at the Children’s Hospital of Boston, and the Charles A. Janeway Professor of Pediatrics and professor of genetics at Harvard Medical School, received the 44th AACR-G.H.A. Clowes Memorial Award for his major discoveries involving genomic stability and cancer.
David Sidransky, M.D., was honored with the 28th AACR-Richard & Hinda Rosenthal Foundation Award for making a notable contribution to improved clinical care in the field of cancer. Sidransky is a professor of otolaryngology, oncology, urology, genetics, pathology, and cellular and molecular medicine and director of head and neck cancer research at the Johns Hopkins University School of Medicine in Baltimore, Md.
Dennis A. Carson, M.D., professor in the Department of Medicine and director of the Rebecca and John Moores University of California at San Diego Cancer Center, won the 23rd AACR-Bruce F. Cain Memorial Award for developing and seeing through to its clinical use an effective therapy for hairy cell leukemia, as well as discovering a number of cancer-producing mutations that have led to other specifically targeted patient therapies.
Malcolm C. Pike, Ph.D., professor at the Keck School of Medicine, University of Southern California, Los Angeles, earned the 13th AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention for his contributions to the prevention of hormone-related cancers, particularly breast cancer.
Clara D. Bloomfield, M.D., William G. Pace III professor of cancer research at the Ohio State University Comprehensive Cancer Center, received the 9th AACR-Joseph H. Burchenal Clinical Cancer Research Award. Bloomfield will be honored for her pioneering clinical research over three decades in adult leukemia and lymphoma that has improved patient treatment, especially through her demonstration that older patients can be cured with appropriate therapy.
Xiaodong Wang, Ph.D., George L. MacGregor distinguished chair in biomedical science at the University of Texas Southwestern Medical Center at Dallas, received the AACR Award for Outstanding Achievement in Cancer Research. The award honors an accomplished young investigator in the field who is no more than 40 years old at the time the award is conferred. Wang was recognized for important discoveries concerning the biochemical mechanisms of apoptosis.
Paul Talalay, M.D., John Jacob Abel Distinguished Service Professor in the Department of Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, was selected to deliver the 9th AACR-DeWitt S. Goodman Memorial Lecture. Talalay was honored for his seminal and continued contributions to basic and translational aspects of chemoprevention research.
Titia de Lange, Ph.D., Leon Hess Professor at The Rockefeller University in New York, was invited to deliver the 7th AACR-Women in Cancer Research Charlotte Friend Memorial Lecture. de Lange was honored for her body of scientific work elucidating the role of the telomere in chromosome structure, cellular growth, and cancer.
The American-Italian Cancer Foundation is accepting nominations for the AICF Prize for Scientific Excellence in Medicine. This award recognizes a major scientific discovery in basic or translational cancer research that has reached the early stages of clinical trials and showed promise. Each award of $50,000 will be presented to one U.S. and one European scientist.
The prize will be presented at the Foundation’s Annual Benefit Gala on November 15. Nominations may be made by any scientist currently or previously affiliated with a cancer research institution or an advocacy organization. Candidates may not nominate themselves for this award. Nominations are due by May 3, 2004, and the winners will be notified no later than June 30, 2004.
Nomination package requirements are available from AICF at http://www.aicfonline.org or by e-mailing aicf{at}aicfonline.org.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||